Press Releases – Page 5 – CellCentric

Press and media

Press releases

More regular updates and key information, updates and news can be found on the CellCentric LinkedIn page.

CellCentric and ZoBio enter into partnership to develop lead compounds against epigenetic drug targets

20 June 2012 Press Release

New consortium to investigate epigenetics and metabolic disorders

8 December 2011 Press Release

CellCentric CEO appointed to BBSRC Council

5 April 2011 Press Release

CellCentric closes first tranche of series B financing

14 March 2011 Press Release

CellCentric featured in Nature Biotechnology

9 December 2010 Press Release

CellCentric publishes on non-oncology indications

18 November 2010 Press Release

CellCentric’s scientific founder awarded Royal Medal

31 August 2010 Press Release

CellCentric key collaborator awarded FRS

24 May 2010 Press Release

CellCentric receives two research awards from the BBSRC

11 May 2010 Press Release

CellCentric licenses novel epigenetic discovery programme to Takeda

23 February 2010 Press Release

CellCentric heads new collaboration with Sigma-Aldrich, The Automation Partnership and leading epigenetic researchers

16 February 2010 Press Release

CellCentric epigenetic imprint erasure factor published in Nature

25 January 2010 Press Release

Inobrodib

A first-in-class oral
anti-cancer drug